Coadministration of Basic Fibroblast Growth Factor and Sucrose Octasulfate (Sucralfate) Facilitates the Rat Dorsal Flap Survival and Viability
Authors:
- Sadanori AkitaSadanori Akita
- Mohammed Shawkat RazzaqueMRMohammed Shawkat Razzaque
- Hiroshi YoshimotoHYHiroshi Yoshimoto
- Hiroshi IshiharaHIHiroshi Ishihara
- Tohru FujiiTFTohru Fujii
- Katsumi TanakaKTKatsumi Tanaka
- Takashi TaguchiTTTakashi Taguchi
- 1 March 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 103 (3) , 941-948
Abstract
The effective use of local growth factors and cytokines may replace the lengthy staged surgical delay process. We tested the efficacy of basic fibroblast growth factor (bFGF) coadministered with sucralfate (sucrose octasulfate) on the rat dorsal flap model. A total of 76 male Wistar rats were used in this experiment. Four groups of the animals were divided. Group 1 (n = 5) was the vehicle control (saline soaked), group 2 (n = 5) was sucrose octasulfate soaked (100 μg/ml, 1 ml), group 3 (n = 5) was bFGF soaked (1 μg/ml, 1 ml), and group 4 (n = 5) was both bFGF and sucrose octasulfate soaked. All agents were soaked equally in Gelfoam. The flap survival measured by the quantitative computer-assisted morphologic analysis was significantly improved by day 5 postoperatively in the combined administration group compared with the vehicle control (81 and 53 percent, respectively; p < 0.05). In lead oxide-gelatin microangiography, there was enhanced pedicle vessel formation observed as well as the extended vessel sprouting up to very close to the distal end in combined group on day 5. The endogenous bFGF mRNA expressions shown by reverse transcriptase-polymerase chain reaction were detected in all four groups. The angiogenesis indicated by α-smooth muscle actin immunopositivity was significantly more enhanced in the combined group than the vehicle control (37.3 and 19.4, respectively; p < 0.01). In the combined group, there was stronger immunopositivity for bFGF in epidermis and hair follicles observed, and more notably bFGF-immunopositive dermal fibroblasts were evident. Thus, coadministration of bFGF and sucralfate markedly facilitates the rat dorsal flap survivability by enhancing the bFGF expression and angiogenesis. (Plast. Reconstr. Surg. 103: 941, 1999.)Keywords
This publication has 12 references indexed in Scilit:
- Stimulation of Angiogenesis to Improve the Viability of Prefabricated FlapsPlastic and Reconstructive Surgery, 1998
- Collagen-binding heat shock protein (HSP) 47 expression in anti-thymocyte serum (ATS)-induced glomerulonephritisThe Journal of Pathology, 1997
- Quantitation of Angiogenesis and Antiangiogenesis in the Chick Embryo Chorioallantoic MembraneMicrovascular Research, 1994
- Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition.Proceedings of the National Academy of Sciences, 1993
- Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds.Journal of Clinical Investigation, 1989
- Angiogenic FactorsScience, 1987
- Fibroblast growth factor: Structural and biological propertiesJournal of Cellular Physiology, 1987
- Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells invitro: Implications for a role of heparinase-like enzymes in the neovascular responseBiochemical and Biophysical Research Communications, 1987
- A Simplified Lead Oxide Cadaver Injection TechniquePlastic and Reconstructive Surgery, 1986
- THE DESIGN OF A PEDICLE FLAP IN THE RAT TO STUDY NECROSIS AND ITS PREVENTIONPlastic and Reconstructive Surgery, 1965